Cannabis Central: Cronos' Q3 Financial Report Shows Impressive Increase In Revenue But Not Much Else

Cronos' Q3 financials showed slight improvement but were still in negative territory on almost all counts. Cronos' stock price is down 22.0% YTD, was UP 19.4% in October and is showing surprising strength today in spite of the unimpressive results.